Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-314743
Filing Date
2022-12-29
Accepted
2022-12-29 16:06:33
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d420468ds3.htm S-3 178417
2 EX-5.1 d420468dex51.htm EX-5.1 9165
3 EX-23.2 d420468dex232.htm EX-23.2 1755
4 EX-FILING FEES d420468dexfilingfees.htm EX-FILING FEES 17549
5 GRAPHIC g420468fenwi.jpg GRAPHIC 6539
6 GRAPHIC g420468g01a03.jpg GRAPHIC 46805
  Complete submission text file 0001193125-22-314743.txt   281857
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269059 | Film No.: 221498911
SIC: 2835 In Vitro & In Vivo Diagnostic Substances